Ludao Pei Medical Group

Ludao Pei Medical Group: Founded by Academician Lu Daopei at the beginning of this century, Ludao Pei Medical Group is a private medical group dedicated to the treatment, research, and teaching of hematological diseases and tumors. After more than a decade of unremitting efforts, it has developed into five medical institutions: Hebei Yanda Ludao Pei Hospital, Beijing Ludao Pei Hospital, Beijing Ludao Pei Hematology Hospital, Ludao Pei Hematology Research Institute, and Shanghai Dao Pei Hospital. The Ludao Pei Medical Group has a total of over 700 beds and 90 laminar flow sterile wards of Grade 100. The medical team led by Academician Lu comprises over 300 members, including distinguished professors and doctoral supervisors who are leaders in the field, as well as accomplished young talents with doctoral and master's degrees. The group also boasts a well-trained workforce in testing, nursing, nutrition, rehabilitation, administration, logistics, and social services, always ready to serve patients in line with the principle of "All for Patients." Ludao Pei Medical Group is one of the most active hematopoietic stem cell transplantation centers in the world, performing about 10% of the national total annual transplants. It also handles the largest number of refractory, relapsed, and salvage hematopoietic stem cell transplants in China, achieving results comparable to unrelated donor and sibling matched transplants with haploidentical transplants. In 2018, 773 transplants were performed, with haploidentical transplants accounting for over 70%. The Ludao Pei medical team actively engages in academic exchanges and international cooperation. They integrate top medical technology, cutting-edge research, efficient medical processes, and humanized services, focusing on medical care, research, and teaching to build a first-class private medical group in China. Yanda Ludao Pei Hospital: Hebei Yanda Ludao Pei Hospital, located in Yanda International Health City in Yanda Economic Development Zone, has 350 beds and 54 laminar flow sterile wards of Grade 100, making it a tertiary specialized hematology hospital that integrates medical care, teaching, and research. The hospital's medical team consists of over 100 staff and its laboratory team over 100, including academicians of the Chinese Academy of Engineering, professors, doctoral supervisors, and experts in hematology and oncology who studied in the United States, as well as young talents with medical doctorates and master's degrees who have made significant contributions in clinical practice and research. There is also a nursing team of over 300 well-trained and skilled personnel. As one of the most active hematopoietic stem cell transplantation centers in the world, the bone marrow transplantation department performs about one-tenth of the national total allogeneic transplants, with 717 transplants completed in 2018. The hematology department currently has two medical teams, treating a large number of patients with refractory and relapsed malignant hematological diseases, and also has unique diagnostic and treatment experience for non-malignant hematological diseases. The clinical research results of chemotherapy combined with CIK cells and allogeneic NK cell therapy for low- and intermediate-risk malignant hematological tumors have been recognized by international hematology institutions. In recent years, the use of CD19 CAR-T technology to treat refractory/relapsed acute B-cell lymphoblastic leukemia (B-ALL), lymphoma, and multiple myeloma has led in both case numbers and treatment outcomes among domestic medical institutions. The International Lymphoma and Myeloma Center provides patients with precise clinical diagnosis and disease assessment, monitoring drug concentrations, adverse effects, and minimal residual disease during treatment, adjusting strategies flexibly to maximize the chance of cure. The clinical laboratory has over 160 professional technical staff in hematology, equipped with first-class laboratory facilities and high-quality reagents. It includes departments for cell morphology, immunophenotyping, cytogenetics and molecular genetics, clinical pharmacology, pathology, and pathogenic microbiology, seamlessly connected. In addition to performing tests for inpatients, it also handles sample testing for nearly 100 public Class A tertiary hospitals nationwide. The team can also develop new tests based on clinical needs to aid in diagnosing difficult cases. Full coverage, fast turnaround, and high accuracy are our greatest advantages. Because of focus, excellence is achieved. Following the principle of "Pragmatism, Innovation, Cooperation, and Win-Win," the hospital actively sponsors and participates in various academic exchange activities and has established partnerships with several world-leading hematology and oncology centers. As an outstanding private hospital nationwide, patient needs are our pursuit. We are constantly striving for the recovery of our patients. Human Resources Department Phone: ***********/***********/Teacher Jia *********** Resume submission email: hr01@* Work location for this position: Inside Yanda Health City, Sipulan Road, Yandai Development Zone, Eastern Beijing. Transportation: Take bus 815, 816, or 817 from Dawang Road or Langjiayuan. Benefits: 1. Social insurance and housing fund 2. National holidays and weekends 3. Staff apartments Website: *